Form 4: Perceptive Advisors LLC Acquires Immatics N.V. Stock Options

Perceptive Advisors LLC reports the acquisition of stock options for Immatics N.V. as part of director compensation.

Summary

• Perceptive Advisors LLC, through its investment manager Perceptive Advisors LLC, has acquired stock options for Immatics N.V. (IMTX).
• The options grant the right to purchase 48,000 ordinary shares at an exercise price of $9.09 per share.
• The grant date was June 16, 2026, with full vesting expected on the first anniversary of the grant date.
• These options are related to Adam Stone's role as a member of Immatics N.V.'s board of directors.
• Perceptive Advisors LLC and Joseph Edelman disclaim beneficial ownership beyond their indirect pecuniary interest.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral; it represents a standard compensation event for a director and does not inherently signal positive or negative performance for the company.

Positives

• Acquisition of stock options by a significant entity (Perceptive Advisors LLC) suggests confidence in the company's future prospects.
• The options are tied to board service, indicating a commitment from management and directors.
• The exercise price of $9.09 per share provides a clear benchmark for potential future profitability.

Negatives

• The filing only details the acquisition of options, not the exercise or sale of shares, so immediate financial gain is not yet realized.
• The reporting person disclaims beneficial ownership beyond indirect pecuniary interest, which could indicate a complex ownership structure.

Risks

• The value of the stock options is subject to market fluctuations and the future performance of Immatics N.V.
• The vesting schedule means the options are not immediately available for exercise.
• Potential for dilution if a large number of options are exercised.

Future Outlook

The stock options are set to vest in full on the first anniversary of the grant date (June 16, 2026), and expire on June 15, 2036. The value of these options is contingent on the future performance of Immatics N.V.'s stock.

Management Comments

• "Consists of options to purchase the Issuer's ordinary shares awarded to Adam Stone in connection with his role as a member of the Issuer's board of directors."
• "The Advisor may be deemed to have an indirect pecuniary interest in the options to purchase common stock of the Issuer reported herein through a partial management fee offset."
• "The Advisor and Mr. Edelman disclaim, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his or its indirect pecuniary interest therein..."

Industry Context

StockSavvy.ai notes that the issuance of stock options as part of director compensation is a common practice in the biotechnology and pharmaceutical sectors, aligning executive and board interests with shareholder value. Immatics N.V. operates in the immuno-oncology space, a highly competitive and capital-intensive field.

Related Party Transactions

• Stock options granted to Adam Stone, Chief Investment Officer of Perceptive Advisors LLC, in connection with his board service at Immatics N.V.

Stakeholder Impact

• Shareholders: The issuance of options does not immediately dilute share count but could lead to dilution if exercised. The alignment of director interests may be viewed positively.
• Employees: Indirect impact through potential company growth and success driven by motivated leadership.
• Management: Adam Stone and Perceptive Advisors LLC have a vested interest in the company's stock performance.

Next Steps

• Vesting of stock options on June 16, 2027.
• Potential exercise of stock options by Adam Stone or Perceptive Advisors LLC before the expiration date of June 15, 2036.

Key Dates

Keywords

Immatics N.V., IMTX, Perceptive Advisors LLC, stock options, SEC Form 4, beneficial ownership, director compensation, Adam Stone, Joseph Edelman